2024
Rate of clinically significant red blood cell antibody seroconversion in pregnancy
Ding J, Abels E, Jacobs J, Culhane J, Lundsberg L, Partridge C, Denoble A, Kohari K. Rate of clinically significant red blood cell antibody seroconversion in pregnancy. The Journal Of Maternal-Fetal & Neonatal Medicine 2024, 37: 2419370. PMID: 39462637, DOI: 10.1080/14767058.2024.2419370.Peer-Reviewed Original ResearchConceptsNeonatal intensive care unitAdvanced maternal ageAssociated with seroconversionClinically significant antibodiesAntibody screeningNeonatal outcomesIncreasing gravidityAntibody seroconversionInitial hemoglobinMaternal ageSignificant antibodiesAntibody statusNeonatal intensive care unit admissionCohort studyClinically significant RBC antibodiesAnti-CUnexplained fetal lossPositive antibody screenNegative antibody screenCases of stillbirthRetrospective cohort studyIntensive care unitWilcoxon rank-sumMaternal antibody statusPostnatal transfusion
2023
Use of family history of cardiovascular disease or chronic hypertension to better identify who needs postpartum cardiovascular risk screening
Ackerman-Banks C, Pudwell J, Lundsberg L, Lipkind H, Smith G. Use of family history of cardiovascular disease or chronic hypertension to better identify who needs postpartum cardiovascular risk screening. American Journal Of Obstetrics & Gynecology MFM 2023, 5: 100850. PMID: 36640863, DOI: 10.1016/j.ajogmf.2022.100850.Peer-Reviewed Original ResearchConceptsPositive family historyFirst-degree family historyChronic hypertensionHypertensive disordersCardiovascular riskFamily historyCardiovascular diseaseUncomplicated pregnanciesControl individualsCardiovascular disease risk scoreBody mass indexDisease risk scoreFirst-degree relativesPregnancy complicationsTerm pregnancyMetabolic syndromeMass indexMyocardial infarctionHypertensionRisk scorePregnancyDiseaseIdentifies individualsDisordersRisk